BSE filing, BSE: 544687. Summary written from the filing by ALFA Finder's alert engine.
Hannah Joseph Hospital Ltd: key numbers
- Share price
- ₹113.00
- Market cap
- ₹256.5 Cr
- Revenue (annual)
- ₹92.05 Cr
- Net profit (annual)
- ₹11.18 Cr
- P/E (TTM)
- 22.9×Sector 52.0×
- Promoter holding
- 71.50%
- FII holding
- 0.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hannah Joseph Hospital Ltd
All →Hannah Joseph Hospital Business Update
Hannah Joseph Hospital received the 'Honours for Healthcare Excellence in Neurosciences' at CII TN MedClave 2026. The award recognises its multidisciplinary Neurosciences services in Tamil Nadu.
Hannah Joseph Hospital Other Announcement
The company filed its quarterly shareholding pattern as mandated by SEBI regulations. This routine disclosure presents the distribution of equity among promoters and public shareholders.
Hannah Joseph Hospital Promoter Buying
Promoter Daniel Dayanand Fenn acquired 2,000 equity shares of Hannah Joseph Hospital Limited through an open market purchase. This transaction increases the total promoter group stake to 71.502%.
- Promoter stake change
- +0.01%
Hannah Joseph Hospital Promoter Buying
Promoter Daniel Dayanand Fenn bought 2,000 open-market Hannah Joseph Hospital shares, raising his stake to 0.053%. A small SAST 29(2) disclosure with no stated transaction price.
- Promoter stake change
- +0.01%
Hannah Joseph Hospital Business Update
Hannah Joseph Hospital Limited received the "Winner" award for "Best Healthcare Digital Initiative" at the 5th CII WR Health Innovation Awards 2026.
- From
- Confederation of Indian Industry (CII)
Hannah Joseph Hospital Business Update
Hannah Joseph Hospital Limited received the AHPI-TN Excellence Award 2026 for Best Single Hospital (above 100 beds) in the Central Zone. This industry recognition highlights its service quality.
Other board meeting date announcements
All →Athena Constructions Board Meeting Date
Athena Constructions scheduled a board meeting for 5 November 2026 to consider its half-year results. The trading window is closed and will reopen after results are declared.
Prime Fresh Board Meeting Date
Prime Fresh scheduled its Board meeting for 06 November 2026 to approve unaudited Q1 and H1 results. Trading window closed from 01 October 2026.
Pokarna Board Meeting Date
Pokarna Ltd intimated that its Board meets on 03 Nov 2026 to consider unaudited Q1 and H1 FY27 results. The trading window stays closed till 05 Nov 2026.
Mahaveer Infoway Board Meeting Date
Mahaveer Infoway Ltd scheduled a board meeting for 3 Nov 2026 to approve Q1 FY27 unaudited results and the limited review report. This is a routine prior intimation under Reg 29(1)(a).
Indowind Energy Board Meeting Date
Indowind Energy scheduled a board meeting on 5 Nov 2026 to approve Q1 FY27 unaudited results. The trading window remains closed until 48 hours post-approval.
Dhunseri Ventures Board Meeting Date
Dhunseri Ventures Ltd intimated that its Board will meet on 6 November 2026, inter alia to approve Q2 FY27 results. The trading window stays closed until 8 November 2026.